Molecular mechanisms of insulin resistance in chronic hepatitis C

Por Douglas, Mark W, George, Jacob
Publicado em 2009

Special Issue “Hepatitis B Virus Infection: From Diagnostics to Treatments”

Por Tu, Thomas, Douglas, Mark W.
Publicado no Viruses (2020)

Lipid Metabolism and HCV Infection

Por Targett-Adams, Paul, Boulant, Steeve, Douglas, Mark W., McLauchlan, John
Publicado em 2010

Cross-Genotypic Examination of Hepatitis C Virus Polymerase Inhibitors Reveals a Novel Mechanism of Action for Thumb Binders

Por Eltahla, Auda A., Tay, Enoch, Douglas, Mark W., White, Peter A.
Publicado no Antimicrob Agents Chemother (2014)

Epidemiology of Coronavirus Disease in Gansu Province, China, 2020

Por Fan, Jingchun, Liu, Xiaodong, Pan, Weimin, Douglas, Mark W., Bao, Shisan
Publicado no Emerg Infect Dis (2020)

The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure

Por Tu, Thomas, Block, Joan M., Wang, Su, Cohen, Chari, Douglas, Mark W.
Publicado no Viruses (2020)

Determination of Interactions between Tegument Proteins of Herpes Simplex Virus Type 1

Por Vittone, Valerio, Diefenbach, Eve, Triffett, Damian, Douglas, Mark W., Cunningham, Anthony L., Diefenbach, Russell J.
Publicado em 2005

Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B

Por Fahrtash-Bahin, Farzan, Kariyawasam, Viraj C, Gray, Timothy, Byth, Karen, George, Jacob, Douglas, Mark W
Publicado em 2013

The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist

Por Read, Scott A., Tay, Enoch S., Shahidi, Mahsa, McLauchlan, John, George, Jacob, Douglas, Mark W.
Publicado no J Interferon Cytokine Res (2015)

Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response

Por Read, Scott A., Tay, Enoch S., Shahidi, Mahsa, O’Connor, Kate S., Booth, David R., George, Jacob, Douglas, Mark W.
Publicado no PLoS One (2015)

COVID-19: The Immune Responses and Clinical Therapy Candidates

Por Zhand, Sareh, Saghaeian Jazi, Marie, Mohammadi, Saeed, Tarighati Rasekhi, Roozbeh, Rostamian, Ghassem, Kalani, Mohammad Reza, Rostamian, Aida, George, Jacob, Douglas, Mark W
Publicado no Int J Mol Sci (2020)

Hepatitis C Virus Induces the Cannabinoid Receptor 1

Por van der Poorten, David, Shahidi, Mahsa, Tay, Enoch, Sesha, Jayshree, Tran, Kayla, McLeod, Duncan, Milliken, Jane S., Ho, Vikki, Hebbard, Lionel W., Douglas, Mark W., George, Jacob
Publicado em 2010

The paradox of HBV evolution as revealed from a 16(th) century mummy

Por Patterson Ross, Zoe, Klunk, Jennifer, Fornaciari, Gino, Giuffra, Valentina, Duchêne, Sebastian, Duggan, Ana T., Poinar, Debi, Douglas, Mark W., Eden, John-Sebastian, Holmes, Edward C., Poinar, Hendrik N.
Publicado no PLoS Pathog (2018)

Correction: The paradox of HBV evolution as revealed from a 16(th) century mummy

Por Patterson Ross, Zoe, Klunk, Jennifer, Fornaciari, Gino, Giuffra, Valentina, Duchêne, Sebastian, Duggan, Ana T., Poinar, Debi, Douglas, Mark W., Eden, John-Sebastian, Holmes, Edward C., Poinar, Hendrik N.
Publicado no PLoS Pathog (2018)

Macrophage Coordination of the Interferon Lambda Immune Response

Por Read, Scott A., Wijaya, Ratna, Ramezani-Moghadam, Mehdi, Tay, Enoch, Schibeci, Steve, Liddle, Christopher, Lam, Vincent W. T., Yuen, Lawrence, Douglas, Mark W., Booth, David, George, Jacob, Ahlenstiel, Golo
Publicado no Front Immunol (2019)

Zinc is a potent and specific inhibitor of IFN-λ3 signalling

Por Read, Scott A., O'Connor, Kate S., Suppiah, Vijay, Ahlenstiel, Chantelle L. E., Obeid, Stephanie, Cook, Kristina M., Cunningham, Anthony, Douglas, Mark W., Hogg, Philip J., Booth, David, George, Jacob, Ahlenstiel, Golo
Publicado no Nat Commun (2017)

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

Por Douglas, Mark W., Tay, Enoch S.E., Wang, Dao Sen, Ong, Adrian T.L., Wilson, Caroline, Phu, Amy, Kok, Jen, Dwyer, Dominic E., Bull, Rowena A., Lloyd, Andrew R., Applegate, Tanya L., Dore, Gregory J., Howe, Anita Y., Harrigan, Richard, George, Jacob
Publicado no Hepatol Commun (2020)

Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review

Por Bartlett, Sofia R., Grebely, Jason, Eltahla, Auda A., Reeves, Jacqueline D., Howe, Anita Y.M., Miller, Veronica, Ceccherini‐Silberstein, Francesca, Bull, Rowena A., Douglas, Mark W., Dore, Gregory J., Harrington, Patrick, Lloyd, Andrew R., Jacka, Brendan, Matthews, Gail V., Wang, Gary P., Pawlotsky, Jean‐Michel, Feld, Jordan J., Schinkel, Janke, Garcia, Federico, Lennerstrand, Johan, Applegate, Tanya L.
Publicado no Hepatol Commun (2017)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Por Thabet, Khaled, Asimakopoulos, Anastasia, Shojaei, Maryam, Romero-Gomez, Manuel, Mangia, Alessandra, Irving, William L., Berg, Thomas, Dore, Gregory J., Grønbæk, Henning, Sheridan, David, Abate, Maria Lorena, Bugianesi, Elisabetta, Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Fischer, Janett, Spengler, Ulrich, Nattermann, Jacob, Wahid, Ahmed, Rojas, Angela, White, Rose, Douglas, Mark W., McLeod, Duncan, Powell, Elizabeth, Liddle, Christopher, van der Poorten, David, George, Jacob, Eslam, Mohammed
Publicado no Nat Commun (2016)

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease

Por Eslam, Mohammed, Hashem, Ahmed M., Leung, Reynold, Romero-Gomez, Manuel, Berg, Thomas, Dore, Gregory J., Chan, Henry L.K., Irving, William L., Sheridan, David, Abate, Maria L., Adams, Leon A., Mangia, Alessandra, Weltman, Martin, Bugianesi, Elisabetta, Spengler, Ulrich, Shaker, Olfat, Fischer, Janett, Mollison, Lindsay, Cheng, Wendy, Powell, Elizabeth, Nattermann, Jacob, Riordan, Stephen, McLeod, Duncan, Armstrong, Nicola J., Douglas, Mark W., Liddle, Christopher, Booth, David R., George, Jacob, Ahlenstiel, Golo
Publicado no Nat Commun (2015)